Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (341-350 of 405) with videos related to

Pageof 41
Sort By:
Journal of Virology|October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Nature Microbiology|April 10, 2025
A broadly protective human antibody for GI genogroup norovirusesInga Rimkute, Adam S Olia, Mehin Suleiman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2016
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 AcquisitionShari N Gordon, Namal P M Liyanage, Melvin N Doster, et al.
The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Journal of Virology|May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimatesXiaoying Shen, Ryan Duffy, Robert Howington, et al.
Journal of Virology|November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein BoostBenedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Journal of Virology|February 12, 2016
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved AntigensBenedikt Asbach, Alexander Kliche, Josef Köstler, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah O'Connell, Stephen D Schmidt, et al.
Plos Pathogens|August 29, 2018
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7Sakaorat Lertjuthaporn, Claudia Cicala, Donald Van Ryk, et al.
Pageof 41

Showing results (341-350 of 405) with videos related to

Sort By:
Pageof 41
Journal of Virology|October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Nature Microbiology|April 10, 2025
A broadly protective human antibody for GI genogroup norovirusesInga Rimkute, Adam S Olia, Mehin Suleiman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2016
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 AcquisitionShari N Gordon, Namal P M Liyanage, Melvin N Doster, et al.
The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Journal of Virology|May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimatesXiaoying Shen, Ryan Duffy, Robert Howington, et al.
Journal of Virology|November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein BoostBenedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Journal of Virology|February 12, 2016
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved AntigensBenedikt Asbach, Alexander Kliche, Josef Köstler, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah O'Connell, Stephen D Schmidt, et al.
Plos Pathogens|August 29, 2018
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7Sakaorat Lertjuthaporn, Claudia Cicala, Donald Van Ryk, et al.
Pageof 41